Clinical trial
Study of Antidepressants in Parkinson's Disease
NCT00086190 · University of Rochester, Other · Completed
Key facts
| NCT number | NCT00086190 |
|---|---|
| Title | Study of Antidepressants in Parkinson's Disease |
| Official title | Study of Antidepressants in Parkinson's Disease |
| Acronym | SAD-PD |
| Lead sponsor | University of Rochester, Other |
| Collaborators | National Institute of Neurological Disorders and Stroke (NINDS) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Parkinson Disease, Depression |
| Intervention type | Drug, Other |
| Interventions | paroxetine, venlafaxine, placebo |
| Enrollment | 115 |
| Start date | Jun 1, 2005 |
| Primary completion | Nov 1, 2009 |
| Completion | Nov 1, 2009 |
| First posted | Jun 29, 2004 |
| Last update posted | Jan 4, 2013 |
| Countries | Canada, Puerto Rico, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: